AVBP · ArriVent BioPharma, Inc.
Market Cap
$1.49B
Shares
49.31M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1868279
CUSIP
04272N102
13F (30d)
140 filings
140 filers
Visit website
Investor relations